Join the club for FREE to access the whole archive and other member benefits.

The first senolytic drugs to target senescent cells


Key points from article :

Senolytic drugs discovered at Mayo effectively clear senescent cells while leaving normal cells unaffected.

New screening platform identified and confirmed a new category of senolytic drugs - HSP90 inhibitors.

Mayo Clinic testes the effects of senolytic drugs on diseases with a localized accumulation of senescent cells.

Study was published in Nature Communications.

New platform will help to identify additional drugs that target ageing processes more quickly

Mentioned in this article:

Tap on icon for description, click on resource name for more details.


Researcher on different aging related diseases.


Journal providing information about clinical aging research


Journal covering all topics in physics, chemistry, and biology.


Innovative research center for aging research and age-related conditions


Medical research facility with focus on research and education in the biomedical sciences.